China's most prestigious general hospital, founded with Rockefeller money in 1921, and a national referral centre for rare, endocrine and gynaecological tumours.
PUMCH was established in 1921 by the Rockefeller Foundation's China Medical Board and remains the teaching hospital of Peking Union Medical College under the Chinese Academy of Medical Sciences. It is the national flagship for difficult diagnoses, with strong departments in gynaecological oncology (gestational trophoblastic disease, ovarian and cervical cancer), pancreatic and hepatobiliary surgery, neuroendocrine tumours, thyroid and pituitary disease, and rare-disease genetics. PUMCH hosts the National Rare Diseases Registry and several national quality-control centres, and its investigators sit on many CSCO guideline panels. Patients can access phase 1-3 trials in gynaecological, pancreatic and neuroendocrine cancers alongside multidisciplinary tumour boards.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-15.
Matched to Peking Union Medical College Hospital, including child institutions. 1,243 works · 11,742 citations · 72% open access · 9% clinical trials · 3% reviews.
Shares CSCO guidelines (China), Robotic & minimally invasive surgery, Pancreatic ductal adenocarcinoma.
Shares Union Hospital, Tongji Medical College, Cervical cancer, Ovarian cancer.
Shares Germline (hereditary) testing, Ovarian cancer, Pancreatic ductal adenocarcinoma.
Shares Thyroid cancer, Neuroendocrine tumours.
Shares Thyroid cancer, Neuroendocrine tumours.
Shares Thyroid cancer, Neuroendocrine tumours.
Shares Thyroid cancer, Neuroendocrine tumours.
Shares Thyroid cancer, Neuroendocrine tumours.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/